Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 227

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression

Open access
Jiang, Yuan, Jiang, Yan-Yi, Xie, Jian-Jun, Mayakonda, Anand, Hazawa, Masaharu, Chen, Li, Xiao, Jin-Fen, Li, Chun-Quan, Huang, Mo-Li, Ding, Ling-Wen, Sun, Qiao-Yang, Xu, Liang, Kanojia, Deepika, Jeitany, Maya, Deng, Jian-Wen, Liao, Lian-Di, Soukiasian, Harmik J., Berman, Benjamin P., Hao, Jia-Jie, Xu, Li-Yan, Li, En-Min, Wang, Ming-Rong, Bi, Xin-Gang, Lin, De-Chen, Koeffler, H. Phillip · 2018 · Nature Communications

Abstract

Squamous cell carcinomas (SCCs) are aggressive malignancies. Previous report demonstrated that master transcription factors (TFs) TP63 and SOX2 exhibited overlapping genomic occupancy in SCCs. However, functional consequence of their frequent co-localization at super-enhancers remains incompletely understood. Here, epigenomic profilings of different types of SCCs reveal that TP63 and SOX2 cooperatively and lineage-specifically regulate long non-coding RNA (lncRNA) CCAT1 expression, through activation of its super-enhancers and promoter. Silencing of CCAT1 substantially reduces cellular growth both in vitro and in vivo, phenotyping the effect of inhibiting either TP63 or SOX2. ChIRP analysis shows that CCAT1 forms a complex with TP63 and SOX2, which regulates EGFR expression by binding to the super-enhancers of EGFR, thereby activating both MEK/ERK1/2 and PI3K/AKT signaling pathways. These results together identify a SCC-specific DNA/RNA/protein complex which activates TP63/SOX2-CCAT1-EGFR cascade and promotes SCC tumorigenesis, advancing our understanding of transcription dysregulation in cancer biology mediated by master TFs and super-enhancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-06081-9

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 227

Metadata

Authors
Jiang, Y., Jiang, Y.-Y., Xie, J.-J., Mayakonda, A., Hazawa, M., Chen, L., Xiao, J.-F., Li, C.-Q., Huang, M.-L., Ding, L.-W., Sun, Q.-Y., Xu, L., Kanojia, D., Jeitany, M., Deng, J.-W., Liao, L.-D., Soukiasian, H. J., Berman, B. P., Hao, J.-J., Xu, L.-Y., Li, E.-M., Wang, M.-R., Bi, X.-G., Lin, D.-C., & Koeffler, H. P.
Venue
Nature Communications
Published
2018-09-06
Volume
9
Issue
1
Pages
3619-3619
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2889051002
Cited by
227
References
11
FWCI
6.84
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. https://app.cochat.ai/papers/10.1038/s41467-018-06081-9
The paper
Jiang, Y., Jiang, Y.-Y., Xie, J.-J., Mayakonda, A., Hazawa, M., Chen, L., Xiao, J.-F., Li, C.-Q., Huang, M.-L., Ding, L.-W., Sun, Q.-Y., Xu, L., Kanojia, D., Jeitany, M., Deng, J.-W., Liao, L.-D., Soukiasian, H. J., Berman, B. P., Hao, J.-J., . . . Koeffler, H. P. (2018). Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nature Communications. https://doi.org/10.1038/s41467-018-06081-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.